Literature DB >> 27569116

Low utilization of obesity medications: What are the implications for clinical care?

Theodore K Kyle1, Fatima Cody Stanford2,3,4.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27569116      PMCID： PMC6100736          DOI： 10.1002/oby.21566

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN： 1930-7381            Impact factor:   5.002


× No keyword cloud information.
  3 in total

1.  Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s.

Authors:  Catherine E Thomas; Elizabeth A Mauer; Alpana P Shukla; Samrat Rathi; Louis J Aronne
Journal:  Obesity (Silver Spring)       Date:  2016-09       Impact factor: 5.002

2.  The new weight-loss drugs, lorcaserin and phentermine-topiramate: slim pickings?

Authors:  Steven Woloshin; Lisa M Schwartz
Journal:  JAMA Intern Med       Date:  2014-04       Impact factor: 21.873

Review 3.  The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA.

Authors:  Charles Baum; Katherine Andino; Eric Wittbrodt; Shelley Stewart; Keith Szymanski; Robin Turpin
Journal:  Pharmacoeconomics       Date:  2015-07       Impact factor: 4.981
  3 in total
  1 in total

Review 1.  The Role of Bariatric Surgery on Diabetes and Diabetic Care Compliance.

Authors:  Hope T Jackson; Chika Anekwe; Julietta Chang; Ivy N Haskins; Fatima Cody Stanford
Journal:  Curr Diab Rep       Date:  2019-11-14       Impact factor: 4.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.